Patient Preference
On average, physicians stated that half of the patients for whom they order a red blood cell transfusion voice con¬ cern about the risks of transfusion; 21% reported that more than four fifths of their patients voice concern. Most phy¬ sicians (85%) believed that patient's de¬ sires should be considered when decid¬ ing whether or not to order a red blood cell transfusion (response, 5 to 8), and many (53%) strongly agreed with that statement (response, 7 to 8). Yet, when asked the extent to which patient concern actually influences their transfusion deci¬ sions, 52% indicated that they were af¬ fected at all by patient preferences, and only 23% indicated that their decisions were greatly influenced (Table 4 ).
Blood Product Cost
Fewer than half of the physicians (44%) estimated the cost of red blood cells within 50% above or below the true cost approximation of $100 ($50 to $150). Similar proportions estimated costs be¬ low and above this range (25% and 30%). Most 
